Diagnostic evaluation of the BD Affirm VPIII assay as a point-of-care test for the diagnosis of bacterial vaginosis,trichomoniasis and candidiasis

Abstract

Untreated sexually transmitted infections and bacterial vaginosis (BV) pose a serious health risk to mother and child. Limited data exist on the use of the BD Affirm™ VPIII assay as a point-of-care test (POCT). The performance of the BD Affirm™ VPIII assay was compared with the BD Max™ vaginal assay for the diagnosis of BV, Trichomonas vaginalis (TV) and Candida spp. A total of 273 pregnant women were enrolled in this study and had provided two self-collected vaginal swabs. Sensitivity, specificity, positive predictive value, negative predictive value and prevalence were calculated. The prevalence of BV, candidiasis and trichomoniasis was 49.4, 57.2 and 10.3%, respectively. The BD Affirm™ VPIII assay showed a moderate sensitivity (79.8%) and a moderate specificity (80.3%) for diagnosing BV in all participants. The BD Affirm™ VPIII assay had an excellent specificity for Candida spp. and TV of 97.4 and 100%, respectively; however, the assay exhibited poor sensitivities of 52.9 and 46.4%, respectively. This study was the first to report on the performance of the BD Affirm™ VPIII assay as a POCT in an antenatal population. The assay was found to be unsuitable as a screening test for vaginal infections in pregnancy.

Keywords

Affirm max pregnant antenatal South Africa bacterial vaginosis prevalence

Get full access to this article

View all access options for this article.

References

Klebanoff

MA.

Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345: 487–493.

Abbai

Reddy

Ramjee

Prevalent bacterial vaginosis infection – a risk factor for incident sexually transmitted infections in women in Durban, South Africa. Int J STD AIDS 2015; 27(14): 1283–1288.

Hay

Czeizel

AE.

Asymptomatic Trichomonas and Candida colonization and pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007; 21: 403–409.

Nwadioha

Egah

Banwat

, et al. Microbial agents of abnormal vaginal discharge in pregnant mothers attending Primary Health Care Centers of Jos, Nigeria. J Clin Med Res 2010; 2: 7–11.

FengQiu

XiaoDong

LiLi

Vaginitis in pregnancy is related to adverse perinatal outcome. Pak J Med Sci 2015; 31: 582–586.

Sobel

JD.

Bacterial vaginosis: clinical manifestations and diagnosis. UpToDate 2019; 1–13.

Ekström

Adolfsson

Ericson

, et al. Vaginal flora and urinary and vaginal group B streptococci in early pregnancy. Gynecology 2013; 1: 6.

Redelinghuys

Ehlers

Bezuidenhoudt

, et al. Assessment of Atopobium vaginae and Gardnerella vaginalis concentrations in a cohort of pregnant South African women. Sex Transm Infect 2017; 1–6.

Aguin

Sobel

JD.

Vulvovaginal candidiasis in pregnancy. Curr Infect Dis Rep 2015; 17: 15–20.

10.

Johnson

Coetzee

Dorrington

RE.

Sentinel surveillance of sexually transmitted infections in South Africa: a review. Sex Transm Infect 2005; 81: 287–293.

11.

Price

Peters

RPH

Steyn

, et al. Prevalence and detection of Trichomonas vaginalis in HIV-infected pregnant women. Sex Transm Dis 2018; 45: 332–336.

12.

Etuketu

Mogaji

Alabi

, et al. Prevalence and risk factors of Trichomonas vaginalis infection among pregnant women receiving antenatal care in Abeokuta, Nigeria. African J Infect Dis 2015; 9: 51–56.

13.

Dept. of Health: RSA. Sexually transmitted infections Management guidelines, 2015.

14.

Zemouri

Kiarie

, et al. The performance of the vaginal discharge syndromic management in treating vaginal and cervical infection: a systematic review and meta-analysis. PLoS One 2016; 11: 1–21.

15.

van der Eem

Dubbink

Struthers

, et al. Evaluation of syndromic management guidelines for treatment of sexually transmitted infections in South African women. Trop Med Int Health 2016; 21: 1138–1146.

16.

Moodley

Sebitloane

, et al. High prevalence and incidence of asymptomatic sexually transmitted infections during pregnancy and postdelivery in KwaZulu Natal, South Africa. Sex Transm Dis 2015; 42: 43–47.

17.

Paradis

Lejeune

Elevating the standard of care for women’s health: the BD MAX™ Vaginal Panel and Management of Vaginal Infections. BD Life Sciences-Diagnostic Systems: 1–8.

18.

Cartwright

Lembke

Ramachandran

, et al. Comparison of nucleic acid amplification assays with BD Affirm VPIII for diagnosis of vaginitis in symptomatic women. J Clin Microbiol 2013; 51: 3694–3699.

19.

Briselden

Hillier

SL.

Evaluation of affirm VP microbial identification test for Gardnerella vaginalis and Trichomonas vaginalis. J Clin Microbiol 1994; 32: 148–152.

20.

Crist

Bankert

Mallory

, et al. Comparison of the BD Affirm VPIII test to primary care and clinical laboratory methods for the diagnosis of bacterial vaginosis and yeast vaginitis. Infect Dis Clin Pract 2011; 19: 273–275.

21.

Gaydos

Beqaj

Schwebke

, et al. Clinical validation of a test for the diagnosis of vaginitis. Obstet Gynecol 2017; 130: 181–189.

22.

Torrone

Morrison

Chen

, et al. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: an individual participant data meta-analysis of 18 HIV prevention studies. PLoS Med 2018; 15: 1–38.

23.

Mlisana

Naicker

Werner

, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis 2012; 206: 6–14.

24.

Johnson

Dorrington

Bradshaw

, et al. The effect of syndromic management interventions on the prevalence of sexually transmitted infections in South Africa. Sex Reprod Healthc 2011; 2: 13–20.

25.

Mashamba-Thompson

Jama

Sartorius

, et al. Implementation of point-of-care diagnostics in rural primary healthcare clinics in South Africa: perspectives of key stakeholders. Diagnostics 2017; 7: 3.

26.

Schwebke

Muzny

Josey

WE.

Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model. J Infect Dis 2014; 210: 338–343.

27.

Thompson

Timm

Borders

, et al. Diagnostic performance of two molecular assays for the detection of vaginitis in symptomatic women. Eur J Clin Microbiol Infect Dis. Epub ahead of print 9 September 2019. DOI: 10.1007/s10096-019-03694-w.